(AUGUST 29, 2022) Tim Lahey, M.D., M.M.Sc., professor of infectious disease, spoke with Alexandra Montgomery of WCAX-TV Channel 3 about the new bivalent vaccines designed to target more than one strain of COVID-19.
Tim Lahey, M.D., M.M.Sc.
(AUGUST 29, 2022) New bivalent COVID-19 vaccines that will target more than one strain will be available soon to people 12 years of age and older in the U.S., infectious disease specialist Tim Lahey, M.D., M.M.Sc., professor of medicine, told WCAX-TV. The new vaccines “contain proteins from the original virus causing COVID-19, as well as updated versions more similar to what’s circulating now,” Lahey said. Currently, BA.5 is the strain most prevalent in the U.S. and has been since June. If the expected timeline goes through, Vermonters could get the vaccine by mid-September.